Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Jul;15(3):214-6.
doi: 10.4103/2230-8210.83409.

A rare case of synchronous adrenocortical carcinoma and renal cell carcinoma

Affiliations
Case Reports

A rare case of synchronous adrenocortical carcinoma and renal cell carcinoma

Urmila Majhi et al. Indian J Endocrinol Metab. 2011 Jul.

Abstract

We present here a rare case of synchronous adrenocortical carcinoma (ACC) and renal cell carcinoma (RCC). A 27-year-old woman presented with gradual abdominal distension, hematuria, and loss of weight of 3-months duration. She gave a history of treatment for hypertension. The computed axial tomography (CT) scan revealed a large retroperitoneal mass. Her urinary VMA was slightly elevated. Her 24-h urinary metanephrine level was normal. The patient underwent left adrenalectomy, left nephrectomy, spleenectomy, and distal pancreactomy with segmental colonic resection. Postoperative pathology revealed ACC of left suprarenal measuring 22 × 19 × 18 cm(3) and RCC involving the left upper pole of kidney measuring 3 × 2 × 1 cm(3).

Keywords: Adrenalectomy; adrenocortical carcinoma; renal cell carcinoma.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Adrenocortical carcinoma (H and E): (a) Pleomorphic tumor cells showing bizarre hyperchromatic nuclei (×40). (b) Sheet of pleomorphic tumor cells showing necrosis at the top (×40), (c) Mitotic activity by tumor cells (×100), and (d) tumor shows vascular invasion, marked as VI (×20)
Figure 2
Figure 2
Adrenocortical carcinoma (immunehistochemistry). Tumor cells showing positive reaction for (a) Inhibin (×40), (b) Ki 67 (×40), (c) C-Kit (×40), (d) Melan A (×40)
Figure 3
Figure 3
Renal cell carcinoma (H and E). (a) Large tumor cells with mostly clear cytoplasm are seen. Renal capsule and few renal tubules are seen at the periphery (H and E, ×10). (b) Large pleomorphic tumor cells both with clear cytoplasm and eosinophilic granular cytoplasm (H and E, ×40). (c) Pleomorphic tumor cells showing positivity for Keratin (IHC, ×40) and (d) Tumor cells showing positivity for EMA (IHC, ×40).

References

    1. Peppa M, Pikounis V, Papaxoinis G, Macheras A, Economopoulos T, Raptis SA, et al. Adrenocortical carcinoma secreting cortisol, androgens and aldosterone: A case report. Cases J. 2009;2:8951. - PMC - PubMed
    1. Wick MR, Cherwitz DL, McGlennen RC. Adrenocortical carcinoma.An immunohistochemical comparison with renal cell carcinoma. Am J Pathol. 1986;122:343–52. - PMC - PubMed
    1. Foucar E, Dehner LP. Renal cell carcinoma occurring with contralateral adrenal metastasis: A clinical and pathologic trap. Arch Surg. 1979;114:955–63. - PubMed
    1. Ishida M, Kojima K, Ohtomo K. Renal cell carcinoma with double synchronous contralateral adrenal metastases. Korean J Urol. 2010;51:879–81. - PMC - PubMed
    1. Jani P, Nasr AL, Demellawy DE. Synchronous renal cell carcinoma and adrenocortical carcinoma: A rare case report and clinicopathologic approach. Can J Urol. 2008;15:4016–9. - PubMed

Publication types